Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis
Frank M. Brunkhorst, M.D., Christoph Engel, M.D., Frank Bloos, M.D., Ph.D., Andreas Meier-Hellmann, M.D., Max Ragaller, M.D., Norbert Weiler, M.D., Onnen Moerer, M.D., Matthias Gruendling, M.D., Michael Oppert, M.D., Stefan Grond, M.D., Derk Olthoff, M.D., Ulrich Jaschinski, M.D., Stefan John, M.D., Rolf Rossaint, M.D., Tobias Welte, M.D., Martin Schaefer, M.D., Peter Kern, M.D., Evelyn Kuhnt, M.Sc., Michael Kiehntopf, M.D., Christiane Hartog, M.D., Charles Natanson, M.D., Markus Loeffler, M.D., Ph.D., Konrad Reinhart, M.D., for the German Competence Network Sepsis (SepNet)
Background The role of intensive insulin therapy in patientswith severe sepsis is uncertain. Fluid resuscitation improvessurvival among patients with septic shock, but evidence is lackingto support the choice of either crystalloids or colloids.
Methods In a multicenter, two-by-two factorial trial, we randomlyassigned patients with severe sepsis to receive either intensiveinsulin therapy to maintain euglycemia or conventional insulintherapy and either 10% pentastarch, a low-molecular-weight hydroxyethylstarch (HES 200/0.5), or modified Ringer's lactate for fluidresuscitation. The rate of death at 28 days and the mean scorefor organ failure were coprimary end points.
Results The trial was stopped early for safety reasons. Among537 patients who could be evaluated, the mean morning bloodglucose level was lower in the intensive-therapy group (112mg per deciliter [6.2 mmol per liter]) than in the conventional-therapygroup (151 mg per deciliter [8.4 mmol per liter], P<0.001).However, at 28 days, there was no significant difference betweenthe two groups in the rate of death or the mean score for organfailure. The rate of severe hypoglycemia (glucose level, 40mg per deciliter [2.2 mmol per liter]) was higher in the intensive-therapygroup than in the conventional-therapy group (17.0% vs. 4.1%,P<0.001), as was the rate of serious adverse events (10.9%vs. 5.2%, P=0.01). HES therapy was associated with higher ratesof acute renal failure and renal-replacement therapy than wasRinger's lactate.
Conclusions The use of intensive insulin therapy placed criticallyill patients with sepsis at increased risk for serious adverseevents related to hypoglycemia. As used in this study, HES washarmful, and its toxicity increased with accumulating doses.(ClinicalTrials.gov number, NCT00135473
[ClinicalTrials.gov]
.)
Source Information
The authors' affiliations are listed in the Appendix. The investigators who participated in the Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP) study are listed in the Supplementary Appendix, available with the full text of this article at www.nejm.org. Drs. Brunkhorst and Engel contributed equally to the article.
Address reprint requests to Dr. Reinhart at the Department of Anesthesiology and Intensive Care Medicine, Friedrich Schiller University of Jena, Erlanger Allee 101, 07747 Jena, Germany, or at konrad.reinhart{at}med.uni-jena.de.
Insulin and Pentastarch for Severe Sepsis
Lacherade J.-C., Outin H., De Jonghe B., Bracco D., Schricker T., Carvalho G., Muller L., Jaber S., Lefrant J. Y., Van den Berghe G., Wilmer A., Bouillon R., Ellger B., van den Heuvel I., Poelaert J., Brunkhorst F. M., Reinhart K., Engel C.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:2071-2075, May 8, 2008.
Correspondence
This article has been cited by other articles:
Boldt, J., Suttner, S., Brosch, C., Lehmann, A., Rohm, K., Mengistu, A.
(2009). Cardiopulmonary Bypass Priming Using a High Dose of a Balanced Hydroxyethyl Starch Versus an Albumin-Based Priming Strategy. Anesth. Analg.
109: 1752-1762
[Abstract][Full Text]
Flanders, S. J., Juneja, R., Roudebush, C. P., Carroll, J., Golas, A., Elias, B. L.
(2009). Glycemic Control and Insulin Safety: The Impact of Computerized Intravenous Insulin Dosing. American Journal of Medical Quality
24: 489-497
[Abstract]
Hanefeld, M., Bornstein, S. R., Pistrosch, F.
(2009). Shifting the Disease Management Paradigm From Glucose: What are the cons?. Diabetes Care
32: S353-S356
[Full Text]
Sheehy, A. M., Coursin, D. B., Keegan, M. T.
(2009). Risks of tight glycemic control during adult cardiac surgery.. Ann. Thorac. Surg.
88: 1384-1385
[Full Text]
Okabayashi, T., Nishimori, I., Yamashita, K., Sugimoto, T., Maeda, H., Yatabe, T., Kohsaki, T., Kobayashi, M., Hanazaki, K.
(2009). Continuous Postoperative Blood Glucose Monitoring and Control by Artificial Pancreas in Patients Having Pancreatic Resection: A Prospective Randomized Clinical Trial. Arch Surg
144: 933-937
[Abstract][Full Text]
Joseph, J., Sinha, A., Paech, M., Walters, B. N J
(2009). Sepsis in pregnancy and early goal-directed therapy. Obstet Med
2: 93-99
[Abstract][Full Text]
Webster, N. R., Galley, H. F.
(2009). Does strict glucose control improve outcome?. Br J Anaesth
103: 331-334
[Full Text]
Cyrus, R. M, Szumita, P. M, Greenwood, B. C, Pendergrass, M. L
(2009). Evaluation of Compliance with a Paper-based, Multiplication-factor, Intravenous Insulin Protocol. The Annals of Pharmacotherapy
43: 1413-1418
[Abstract][Full Text]
Boldt, J.
(2009). Seven misconceptions regarding volume therapy strategies--and their correction. Br J Anaesth
103: 147-151
[Full Text]
Okabayashi, T., Nishimori, I., Maeda, H., Yamashita, K., Yatabe, T., Hanazaki, K.
(2009). Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial. Diabetes Care
32: 1425-1427
[Abstract][Full Text]
Kapoor, J. R., Kapoor, R.
(2009). Strict glucose control in the cardiac intensive care unit poised for real time?. J Am Coll Cardiol
54: 373-374
[Full Text]
Turchin, A., Matheny, M. E., Shubina, M., Scanlon, J. V., Greenwood, B., Pendergrass, M. L.
(2009). Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward. Diabetes Care
32: 1153-1157
[Abstract][Full Text]
Liu, B., Finfer, S.
(2009). Intravenous fluids in adults undergoing surgery. BMJ
338: b2418-b2418
[Full Text]
Comi, R. J.
(2009). Glucose Control in the Intensive Care Unit: A Roller Coaster Ride or a Swinging Pendulum?. ANN INTERN MED
150: 809-811
[Abstract][Full Text]
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., Umpierrez, G. E.
(2009). American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Diabetes Care
32: 1119-1131
[Full Text]
Fowler, R. A., Adhikari, N. K. J., Scales, D. C., Lee, W. L., Rubenfeld, G. D.
(2009). Update in Critical Care 2008. Am. J. Respir. Crit. Care Med.
179: 743-758
[Full Text]
Blaha, J., Kopecky, P., Matias, M., Hovorka, R., Kunstyr, J., Kotulak, T., Lips, M., Rubes, D., Stritesky, M., Lindner, J., Semrad, M., Haluzik, M.
(2009). Comparison of Three Protocols for Tight Glycemic Control in Cardiac Surgery Patients. Diabetes Care
32: 757-761
[Abstract][Full Text]
Bellomo, R., Egi, M.
(2009). What Is a NICE-SUGAR for Patients in the Intensive Care Unit?. Mayo Clin Proc.
84: 400-402
[Full Text]
Boldt, J.
(2009). Modern Rapidly Degradable Hydroxyethyl Starches: Current Concepts. Anesth. Analg.
108: 1574-1582
[Abstract][Full Text]
Mayer, S. A., Schwab, S.
(2009). Advances in Critical Care and Emergency Medicine. Stroke
40: e298-e300
[Full Text]
Griesdale, D. E.G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., Talmor, D.
(2009). Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ
180: 821-827
[Abstract][Full Text]
Inzucchi, S. E., Siegel, M. D.
(2009). Glucose Control in the ICU -- How Tight Is Too Tight?. NEJM
360: 1346-1349
[Full Text]
The NICE-SUGAR Study Investigators,
(2009). Intensive versus Conventional Glucose Control in Critically Ill Patients. NEJM
360: 1283-1297
[Abstract][Full Text]
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., Service, F. J.
(2009). Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab.
94: 709-728
[Abstract][Full Text]
Dandona, P., Chaudhuri, A., Ghanim, H., Mohanty, P.
(2009). Insulin as an anti-inflammatory and antiatherogenic modulator.. J Am Coll Cardiol
53: S14-S20
[Abstract][Full Text]
Balasubramanyam, A.
(2009). Intensive Glycemic Control in the Intensive Care Unit: Promises and Pitfalls. J. Clin. Endocrinol. Metab.
94: 416-417
[Full Text]
van der Crabben, S. N., Blumer, R. M. E., Stegenga, M. E., Ackermans, M. T., Endert, E., Tanck, M. W. T., Serlie, M. J., van der Poll, T., Sauerwein, H. P.
(2009). Early Endotoxemia Increases Peripheral and Hepatic Insulin Sensitivity in Healthy Humans. J. Clin. Endocrinol. Metab.
94: 463-468
[Abstract][Full Text]
Hartog, C., Brunkhorst, F., Reinhart, K.
(2009). Hydroxyethyl Starch 130/0.4 and Surgical Blood Loss. Anesth. Analg.
108: 672-672
[Full Text]
Hirsch, I. B.
(2009). Sliding Scale Insulin--Time to Stop Sliding. JAMA
301: 213-214
[Full Text]
Zimmerman, J. L.
(2009). Hemodynamic Monitoring and Shock. ACCP Pulmonary Med Brd Rev
25: 345-358
[Full Text]
Gropper, M. A.
(2009). Issues in Postoperative Management: Postoperative Pain Management and Intensive Glycemic Control. ACCP Crit Care Med Brd Rev
20: 425-432
[Full Text]
Sharma, D., Jelacic, J., Chennuri, R., Chaiwat, O., Chandler, W., Vavilala, M. S.
(2009). Incidence and Risk Factors for Perioperative Hyperglycemia in Children with Traumatic Brain Injury. Anesth. Analg.
108: 81-89
[Abstract][Full Text]
American Diabetes Association,
(2009). Standards of Medical Care in Diabetes--2009. Diabetes Care
32: S13-S61
[Full Text]
Preiser, J.-C., Devos, P.
(2008). Tight Glucose Control in Critically Ill Adults. JAMA
300: 2726-2726
[Full Text]
Neumar, R. W., Nolan, J. P., Adrie, C., Aibiki, M., Berg, R. A., Bottiger, B. W., Callaway, C., Clark, R. S.B., Geocadin, R. G., Jauch, E. C., Kern, K. B., Laurent, I., Longstreth, W.T. Jr, Merchant, R. M., Morley, P., Morrison, L. J., Nadkarni, V., Peberdy, M. A., Rivers, E. P., Rodriguez-Nunez, A., Sellke, F. W., Spaulding, C., Sunde, K., Vanden Hoek, T.
(2008). Post-Cardiac Arrest Syndrome: Epidemiology, Pathophysiology, Treatment, and Prognostication A Consensus Statement From the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation
118: 2452-2483
[Full Text]
Kruyt, N D, Roos, Y W B M, Dorhout Mees, S M, van den Bergh, W M, Algra, A, Rinkel, G J E, Biessels, G J
(2008). High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J. Neurol. Neurosurg. Psychiatry
79: 1382-1385
[Abstract][Full Text]
Lameire, N., Van Biesen, W., Hoste, E., Vanholder, R.
(2008). The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI. NDT Plus
1: 392-402
[Abstract][Full Text]
Polito, A., Thiagarajan, R. R., Laussen, P. C., Gauvreau, K., Agus, M. S.D., Scheurer, M. A., Pigula, F. A., Costello, J. M.
(2008). Association Between Intraoperative and Early Postoperative Glucose Levels and Adverse Outcomes After Complex Congenital Heart Surgery. Circulation
118: 2235-2242
[Abstract][Full Text]
Ronco, C., Haapio, M., House, A. A., Anavekar, N., Bellomo, R.
(2008). Cardiorenal Syndrome. J Am Coll Cardiol
52: 1527-1539
[Abstract][Full Text]
Goyal, A., Nerenberg, K., Gerstein, H. C, Umpierrez, G., Wilson, P. W.
(2008). Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points. Diabetes and Vascular Disease Research
5: 276-284
[Abstract]
Boldt, J., Brosch, C., Rohm, K., Lehmann, A., Mengistu, A., Suttner, S.
(2008). Is Albumin Administration in Hypoalbuminemic Elderly Cardiac Surgery Patients of Benefit with Regard to Inflammation, Endothelial Activation, and Long-Term Kidney Function?. Anesth. Analg.
107: 1496-1503
[Abstract][Full Text]
Lansang, M. C., Umpierrez, G. E.
(2008). Management of Inpatient Hyperglycemia in Noncritically Ill Patients. Diabetes Spectr.
21: 248-255
[Abstract][Full Text]
Jamal, R., Ghannoum, M., Naud, J.-F., Turgeon, P.-P., Leblanc, M.
(2008). Permanent renal failure induced by pentastarch. NDT Plus
1: 322-325
[Abstract][Full Text]
Ulate, K. P., Lima Falcao, G. C., Bielefeld, M. R., Morales, J. M., Rotta, A. T.
(2008). Strict Glycemic Targets Need Not Be So Strict: A More Permissive Glycemic Range for Critically Ill Children. Pediatrics
122: e898-e904
[Abstract][Full Text]
Ware, L. B.
(2008). Clinical Year in Review IV: Acute Respiratory Distress Syndrome, Radiology in the Intensive Care Unit, Nonpulmonary Critical Care, and Pulmonary Infections in the Immunocompromised Host. Proc Am Thorac Soc
5: 755-760
[Full Text]
Craig, R. G., Hunter, J. M.
(2008). Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaesth
101: 296-310
[Abstract][Full Text]
Wiener, R. S., Wiener, D. C., Larson, R. J.
(2008). Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis. JAMA
300: 933-944
[Abstract][Full Text]
Kozek-Langenecker, S. A., Jungheinrich, C., Sauermann, W., Van der Linden, P.
(2008). The Effects of Hydroxyethyl Starch 130/0.4 (6%) on Blood Loss and Use of Blood Products in Major Surgery: A Pooled Analysis of Randomized Clinical Trials. Anesth. Analg.
107: 382-390
[Abstract][Full Text]
Ashare, A., Nymon, A. B., Doerschug, K. C., Morrison, J. M., Monick, M. M., Hunninghake, G. W.
(2008). Insulin-like Growth Factor-1 Improves Survival in Sepsis via Enhanced Hepatic Bacterial Clearance. Am. J. Respir. Crit. Care Med.
178: 149-157
[Abstract][Full Text]
Kidd, L. B., Schabbauer, G. A., Luyendyk, J. P., Holscher, T. D., Tilley, R. E., Tencati, M., Mackma, N.
(2008). Insulin Activation of the Phosphatidylinositol 3-Kinase/Protein Kinase B (Akt) Pathway Reduces Lipopolysaccharide-Induced Inflammation in Mice. J. Pharmacol. Exp. Ther.
326: 348-353
[Abstract][Full Text]
Brunkhorst, F. M., Oppert, M., Leone, M., Blasco, V., Albanese, J., Martin, C.
(2008). Nephrotoxicity of hydroxyethyl starch solution. Br J Anaesth
100: 856-857
[Full Text]
Lacherade, J.-C., Outin, H., De Jonghe, B., Bracco, D., Schricker, T., Carvalho, G., Muller, L., Jaber, S., Lefrant, J. Y., Van den Berghe, G., Wilmer, A., Bouillon, R., Ellger, B., van den Heuvel, I., Poelaert, J., Brunkhorst, F. M., Reinhart, K., Engel, C.
(2008). Insulin and Pentastarch for Severe Sepsis. NEJM
358: 2071-2075
[Full Text]
Saberi, F., Heyland, D., Lam, M., Rapson, D., Jeejeebhoy, K.
(2008). Prevalence, Incidence, and Clinical Resolution of Insulin Resistance in Critically Ill Patients: An Observational Study. JPEN J Parenter Enteral Nutr
32: 227-235
[Abstract][Full Text]
Opie, L. H.
(2008). Metabolic Management of Acute Myocardial Infarction Comes to the Fore and Extends Beyond Control of Hyperglycemia. Circulation
117: 2172-2177
[Full Text]
Boldt, J., Brosch, Ch., Rohm, K., Papsdorf, M., Mengistu, A.
(2008). Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth
100: 457-464
[Abstract][Full Text]
Fahy, B. G., Coursin, D. B.
(2008). Critical Glucose Control: The Devil Is in the Details. Mayo Clin Proc.
83: 394-397
[Full Text]
Gandhi, G. Y., Murad, M. H., Flynn, D. N., Erwin, P. J., Cavalcante, A. B., Nielsen, H. B., Capes, S. E., Thorlund, K., Montori, V. M., Devereaux, P. J.
(2008). Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials. Mayo Clin Proc.
83: 418-430
[Abstract][Full Text]
(2008). Intensive Insulin Therapy for Patients with Severe Sepsis? Not So Fast. JWatch General
2008: 1-1
[Full Text]
(2008). Adjunctive Therapy in Septic Shock and Severe Sepsis. JWatch Infect. Diseases
2008: 1-1
[Full Text]